View Older Stories View More Recent Stories

Jun 2, 2025 09:30AM Iovance Biotherapeutics (IOVA) Announces Publication on Amtagvi
Jun 1, 2025 08:48AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
Jun 1, 2025 06:18AM IOVA CLASS ALERT: Iovance Biotherapeutics, Inc. Investors with Losses are Notified to Contact BFA Law about the Securities Fraud Class Action
May 30, 2025 07:16PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
May 30, 2025 12:04PM Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Class Action That Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
May 30, 2025 07:36AM IOVA DEADLINE: BFA Law Alerts Iovance Biotherapeutics, Inc. Investors of the Pending July 14 Class Action Deadline
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 29, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 29, 2025 12:03PM Scott+Scott Attorneys at Law LLP Continues to Remind Investors an Action Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
May 28, 2025 12:02PM Scott+Scott Attorneys at Law LLP Reminds Investors of The Securities Action That Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
May 28, 2025 09:12AM Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over Growth Projections Following Stock Plunge - Hagens Berman
May 28, 2025 07:18AM IOVA SECURITIES UPDATE: Iovance Biotherapeutics, Inc. Investors with Losses are Reminded of the Upcoming July 14 Securities Class Action Deadline
May 27, 2025 12:09PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
May 27, 2025 12:01PM Scott+Scott Attorneys at Law LLP Reminds Investors That There is a Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
May 26, 2025 12:00PM Scott+Scott Attorneys at Law LLP Reminds Investors of the Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
May 26, 2025 08:21AM IOVA SECURITIES: BFA Law Notifies Iovance Biotherapeutics, Inc. Investors to Contact the Firm about the Pending Securities Fraud Class Action by July 14
May 25, 2025 01:17PM ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
May 25, 2025 08:27AM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
May 24, 2025 07:18AM IOVA FRAUD NOTICE: Iovance Biotherapeutics, Inc. Investors with Losses are Reminded to Contact BFA Law about the Pending Securities Fraud Class Action
May 23, 2025 05:10PM Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Iovance Biotherapeutics, Inc. (IOVA)
May 23, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 23, 2025 12:15PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
May 22, 2025 05:32PM Iovance Biotherapeutics (IOVA) announces results of Amtagvi to be presented at ASCO 2025
May 22, 2025 05:05PM Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
May 22, 2025 07:36AM IOVA COURT ALERT: Iovance Biotherapeutics, Inc. Investors are Notified to Contact BFA Law before July 14 Legal Deadline
May 21, 2025 05:00PM Scott+Scott Attorneys at Law LLP Alerts Investors an Action Has Been Filed Against Iovance Biotherapeutics, Inc. (IOVA)
May 20, 2025 05:00PM Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
May 20, 2025 04:36PM Iovance Biotherapeutics (IOVA) Faces Investor Lawsuit Over Growth Projections Following Stock Plunge - Hagens Berman
May 20, 2025 03:42PM IOVA NOTICE: Iovance Biotherapeutics, Inc. Investors with Losses are Alerted of the Upcoming July 14 Deadline in Securities Fraud Class Action
May 20, 2025 10:35AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
May 19, 2025 06:38PM ROSEN, A LEADING LAW FIRM, Encourages Iovance Biotherapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IOVA
May 18, 2025 04:00PM IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 16, 2025 03:14AM UBS Downgrades Iovanace Biotherapeutics (IOVA) to Neutral
May 12, 2025 03:18AM Truist Securities Downgrades Iovanace Biotherapeutics (IOVA) to Hold
May 9, 2025 07:01AM Iovanace Biotherapeutics (IOVA) PT Lowered to $20 at H.C. Wainwright
May 9, 2025 03:23AM Baird Downgrades Iovanace Biotherapeutics (IOVA) to Neutral
May 8, 2025 04:05PM Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 12c
Apr 14, 2025 07:04AM Iovanace Biotherapeutics (IOVA) PT Lowered to $5 at Barclays
Mar 17, 2025 07:58AM Stifel Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
Mar 13, 2025 04:37AM Iovanace Biotherapeutics (IOVA) PT Lowered to $18 at Jefferies
Feb 28, 2025 10:27AM Iovanace Biotherapeutics (IOVA) PT Lowered to $18 at Stifel
Feb 28, 2025 06:46AM Iovanace Biotherapeutics (IOVA) PT Lowered to $6 at Piper Sandler
Feb 27, 2025 04:12PM Iovance Biotherapeutics (IOVA) Tops Q4 EPS by 1c
Feb 12, 2025 09:29AM Stifel Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
Feb 10, 2025 07:00AM Iovance Biotherapeutics (IOVA) Appoints Dan Kirby as Chief Commercial Officer
Feb 4, 2025 08:44AM Iovanace Biotherapeutics (IOVA) PT Lowered to $7.50 at Piper Sandler
Feb 3, 2025 04:43AM JMP Securities Biotechnology Overview
Jan 30, 2025 08:29AM Truist Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA) Following Positive Amtagvi Survey
Jan 27, 2025 09:30AM Stifel Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
Jan 14, 2025 04:57AM Goldman Sachs Reiterates Buy Rating on Iovanace Biotherapeutics (IOVA)
View More Recent Stories View Older Stories